Aveo Pharmaceuticals, Inc.
Clinical trials sponsored by Aveo Pharmaceuticals, Inc., explained in plain language.
-
New drug cocktail aims to extend life in Tough-to-Treat head and neck cancer
Disease control Recruiting nowThis Phase 3 trial is testing whether adding ficlatuzumab to the standard drug cetuximab helps people with recurrent or metastatic HPV-negative head and neck cancer live longer. About 410 adults will be randomly assigned to receive either the combination or a placebo plus cetuxim…
Phase: PHASE3 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug aims to reverse wasting in cancer patients
Symptom relief Recruiting nowThis early-stage trial tests AV-380, an antibody that blocks a protein linked to cancer-related weight loss (cachexia). About 30 adults with advanced solid tumors and high GDF-15 levels will receive AV-380 alongside their standard chemotherapy. The main goal is to check safety an…
Phase: PHASE1 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC